Literature DB >> 8029430

Renal vascular resistance in diabetic nephropathy: duplex Doppler US evaluation.

B Brkljacić1, V Mrzljak, I Drinković, D Soldo, M Sabljar-Matovinović, A Hebrang.   

Abstract

PURPOSE: To evaluate duplex Doppler sonography to assess renal vascular resistance (RVR) in diabetic patients.
MATERIALS AND METHODS: Resistive indexes (RIs) and pulsatility indexes (PIs) were measured in intrarenal arteries of 144 patients with diabetes mellitus and 61 control subjects. RIs and PIs were compared for control subjects and patients with diabetic nephropathy and correlated with laboratory and clinical findings.
RESULTS: In control subjects, the mean RI was 0.595 +/- 0.033 (standard deviation) and mean PI was 1.001 +/- 0.105. Elevated RIs and PIs accompanied progression of nephropathy. Statistically significant (P < .001) correlations were observed between both RI and PI and serum creatinine level, creatinine clearance rate, systolic and diastolic blood pressure measurements, and patient age.
CONCLUSION: Doppler indexes reflect increased RVR in diabetic nephropathy and correlate with laboratory and clinical parameters, but RI and PI measurements offer no advantages over these parameters to predict disease progress or in patient care.

Entities:  

Mesh:

Year:  1994        PMID: 8029430     DOI: 10.1148/radiology.192.2.8029430

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  The role of ultrasonography in the study of medical nephropathy.

Authors:  F Fiorini; L Barozzi
Journal:  J Ultrasound       Date:  2007-11-05

2.  Usefulness of Doppler ultrasound for the early diagnosis of diabetic nephropathy in type 1 diabetes mellitus.

Authors:  Azar Nickavar; Baranak Safaeian; Hossein Zaeri; Mohammad Hadi Gharib; Tahereh Chaharnaei
Journal:  J Ultrasound       Date:  2021-02-20

3.  Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.

Authors:  Haiyang Li; Yunzhu Shen; Zhikai Yu; Yinghui Huang; Ting He; Tangli Xiao; Yan Li; Jiachuan Xiong; Jinghong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.